Super-Responders in Moderate-Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives.
Life (Basel)
; 12(9)2022 Sep 10.
Article
in En
| MEDLINE
| ID: mdl-36143449
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Life (Basel)
Year:
2022
Document type:
Article
Affiliation country:
Spain
Country of publication:
Switzerland